THE USE OF TOCILIZUMAB (ACTEMRA ® ), AN INTERLEUKIN-6 RECEPTOR ANTAGONIST, FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN METHOTREXATE REFRACTORY PATIENTS.
